137 related articles for article (PubMed ID: 37733810)
1. The effect of ascertainment on penetrance estimates for rare variants: Implications for establishing pathogenicity and for genetic counselling.
Paterson AD; Seok SC; Vieland VJ
PLoS One; 2023; 18(9):e0290336. PubMed ID: 37733810
[TBL] [Abstract][Full Text] [Related]
2. Assessing the Pathogenicity, Penetrance, and Expressivity of Putative Disease-Causing Variants in a Population Setting.
Wright CF; West B; Tuke M; Jones SE; Patel K; Laver TW; Beaumont RN; Tyrrell J; Wood AR; Frayling TM; Hattersley AT; Weedon MN
Am J Hum Genet; 2019 Feb; 104(2):275-286. PubMed ID: 30665703
[TBL] [Abstract][Full Text] [Related]
3. Calculating variant penetrance from family history of disease and average family size in population-scale data.
Spargo TP; Opie-Martin S; Bowles H; Lewis CM; Iacoangeli A; Al-Chalabi A
Genome Med; 2022 Dec; 14(1):141. PubMed ID: 36522764
[TBL] [Abstract][Full Text] [Related]
4. Penetrance of schizophrenia-related disorders in multiplex families after correction for ascertainment.
Levinson DF; Mowry BJ; Sharpe L; Endicott J
Genet Epidemiol; 1996; 13(1):11-21. PubMed ID: 8647375
[TBL] [Abstract][Full Text] [Related]
5. Power of pedigree likelihood analysis in extended pedigrees to classify rare variants of uncertain significance in cancer risk genes.
Rosenthal EA; Ranola JMO; Shirts BH
Fam Cancer; 2017 Oct; 16(4):611-620. PubMed ID: 28534081
[TBL] [Abstract][Full Text] [Related]
6. Penetrance estimation of Alzheimer disease in SORL1 loss-of-function variant carriers using a family-based strategy and stratification by APOE genotypes.
Schramm C; Charbonnier C; Zaréa A; Lacour M; Wallon D; ; Boland A; Deleuze JF; Olaso R; ; Alarcon F; Campion D; Nuel G; Nicolas G
Genome Med; 2022 Jun; 14(1):69. PubMed ID: 35761418
[TBL] [Abstract][Full Text] [Related]
7. A Genome-First Approach to Characterize DICER1 Pathogenic Variant Prevalence, Penetrance, and Phenotype.
Mirshahi UL; Kim J; Best AF; Chen ZE; Hu Y; Haley JS; Golden A; Stahl R; Manickam K; Carr AG; Harney LA; Field A; Hatton J; Schultz KAP; Bauer AJ; Hill DA; Rosenberg PS; Murray MF; Carey DJ; Stewart DR
JAMA Netw Open; 2021 Feb; 4(2):e210112. PubMed ID: 33630087
[TBL] [Abstract][Full Text] [Related]
8. GenePy - a score for estimating gene pathogenicity in individuals using next-generation sequencing data.
Mossotto E; Ashton JJ; O'Gorman L; Pengelly RJ; Beattie RM; MacArthur BD; Ennis S
BMC Bioinformatics; 2019 May; 20(1):254. PubMed ID: 31096927
[TBL] [Abstract][Full Text] [Related]
9. Pathogenicity and Penetrance of Germline
Maniam P; Zhou K; Lonergan M; Berg JN; Goudie DR; Newey PJ
J Endocr Soc; 2018 Jul; 2(7):806-816. PubMed ID: 29978154
[TBL] [Abstract][Full Text] [Related]
10. Dilemmas in genetic counseling for low-penetrance neuro-susceptibility loci detected on prenatal chromosomal microarray analysis.
Brabbing-Goldstein D; Reches A; Svirsky R; Bar-Shira A; Yaron Y
Am J Obstet Gynecol; 2018 Feb; 218(2):247.e1-247.e12. PubMed ID: 29146387
[TBL] [Abstract][Full Text] [Related]
11. Evaluating genetic heterogeneity in complex disorders.
Pal DK; Greenberg DA
Hum Hered; 2002; 53(4):216-26. PubMed ID: 12435885
[TBL] [Abstract][Full Text] [Related]
12. Utility of Population-Level DNA Sequence Data in the Diagnosis of Hereditary Endocrine Disease.
Newey PJ; Berg JN; Zhou K; Palmer CNA; Thakker RV
J Endocr Soc; 2017 Dec; 1(12):1507-1526. PubMed ID: 29308445
[TBL] [Abstract][Full Text] [Related]
13. GENETICS IN ENDOCRINOLOGY: Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next-generation sequencing.
Maione L; Dwyer AA; Francou B; Guiochon-Mantel A; Binart N; Bouligand J; Young J
Eur J Endocrinol; 2018 Mar; 178(3):R55-R80. PubMed ID: 29330225
[TBL] [Abstract][Full Text] [Related]
14. Inferring mode of inheritance by comparison of lod scores.
Greenberg DA
Am J Med Genet; 1989 Dec; 34(4):480-6. PubMed ID: 2624256
[TBL] [Abstract][Full Text] [Related]
15. Incomplete Penetrance and Variable Expressivity: From Clinical Studies to Population Cohorts.
Kingdom R; Wright CF
Front Genet; 2022; 13():920390. PubMed ID: 35983412
[TBL] [Abstract][Full Text] [Related]
16. Overcoming the winner's curse: estimating penetrance parameters from case-control data.
Zollner S; Pritchard JK
Am J Hum Genet; 2007 Apr; 80(4):605-15. PubMed ID: 17357068
[TBL] [Abstract][Full Text] [Related]
17. [Genetic diagnostics for cardiomyopathies].
Czepluch F; Wollnik B; Hasenfuß G
Dtsch Med Wochenschr; 2017 May; 142(9):657-664. PubMed ID: 28454199
[TBL] [Abstract][Full Text] [Related]
18. Using lod-score differences to determine mode of inheritance: a simple, robust method even in the presence of heterogeneity and reduced penetrance.
Greenberg DA; Berger B
Am J Hum Genet; 1994 Oct; 55(4):834-40. PubMed ID: 7942860
[TBL] [Abstract][Full Text] [Related]
19. Population Prevalence of Deleterious
LeDoux MS
Tremor Other Hyperkinet Mov (N Y); 2020 Nov; 10():50. PubMed ID: 33200041
[TBL] [Abstract][Full Text] [Related]
20. Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset.
Carayol J; Bonaïti-Pellié C
Genet Epidemiol; 2004 Sep; 27(2):109-17. PubMed ID: 15305327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
